iKang Healthcare (KANG) Reports Q4 EPS of $0.48
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
iKang Announces Unaudited Financial Results for the Fiscal Fourth Quarter and the Fiscal Year 2016 ended March 31, 2017
June 22, 2017 5:00 PM EDTBEIJING, June 22, 2017 (GLOBE NEWSWIRE) -- iKang Healthcare Group, Inc. (iKang or the Company) (Nasdaq: KANG), a major provider in Chinas fast growing private preventive healthcare services market, today announced its unaudited financial results for the fiscal fourth quarter and fiscal year 2016 ended March 31, 2017.
Fiscal Fourth Quarter ended March 31, 2017 Financial Highlights
Net revenues were US$60.2 million, an increase of 13.9% year-over-year (an increase of 19.9% on RMB basis) (1)  Gross profit was US$1.6 million, a decline of 66.0% year-over-year  Non-GAAP EBITDA was loss of US$24.3 million, a decline of 20.5%... More